858 related articles for article (PubMed ID: 22183981)
21. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
Gerken TA; Jamison O; Perrine CL; Collette JC; Moinova H; Ravi L; Markowitz SD; Shen W; Patel H; Tabak LA
J Biol Chem; 2011 Apr; 286(16):14493-507. PubMed ID: 21349845
[TBL] [Abstract][Full Text] [Related]
22. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
23. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
[TBL] [Abstract][Full Text] [Related]
24. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
Pedersen JW; Bennett EP; Schjoldager KT; Meldal M; Holmér AP; Blixt O; Cló E; Levery SB; Clausen H; Wandall HH
J Biol Chem; 2011 Sep; 286(37):32684-96. PubMed ID: 21768105
[TBL] [Abstract][Full Text] [Related]
25. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
26. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
[TBL] [Abstract][Full Text] [Related]
27. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
Gerken TA; Owens CL; Pasumarthy M
J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
[TBL] [Abstract][Full Text] [Related]
28. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase from the snail Biomphalaria glabrata - structural reflections.
Turupcu A; Poliak P; Margreitter C; Oostenbrink C; Staudacher E
Glycoconj J; 2020 Feb; 37(1):15-25. PubMed ID: 31396754
[TBL] [Abstract][Full Text] [Related]
29. The acceptor substrate specificity of porcine submaxillary UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is dependent on the amino acid sequences adjacent to serine and threonine residues.
Wang Y; Agrwal N; Eckhardt AE; Stevens RD; Hill RL
J Biol Chem; 1993 Nov; 268(31):22979-83. PubMed ID: 8226812
[TBL] [Abstract][Full Text] [Related]
30. GALNTs: master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)?
Beaman EM; Carter DRF; Brooks SA
Glycobiology; 2022 Jun; 32(7):556-579. PubMed ID: 35312770
[TBL] [Abstract][Full Text] [Related]
31. An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase.
Collette AM; Hassan SA; Schmidt SI; Lara AJ; Yang W; Samara NL
Sci Adv; 2024 Mar; 10(9):eadj8829. PubMed ID: 38416819
[TBL] [Abstract][Full Text] [Related]
32. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
33. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.
Brockhausen I; Toki D; Brockhausen J; Peters S; Bielfeldt T; Kleen A; Paulsen H; Meldal M; Hagen F; Tabak LA
Glycoconj J; 1996 Oct; 13(5):849-56. PubMed ID: 8910012
[TBL] [Abstract][Full Text] [Related]
34. High level in vivo mucin-type glycosylation in Escherichia coli.
Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S
Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634
[TBL] [Abstract][Full Text] [Related]
35. The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences.
de Las Rivas M; Lira-Navarrete E; Daniel EJP; Compañón I; Coelho H; Diniz A; Jiménez-Barbero J; Peregrina JM; Clausen H; Corzana F; Marcelo F; Jiménez-Osés G; Gerken TA; Hurtado-Guerrero R
Nat Commun; 2017 Dec; 8(1):1959. PubMed ID: 29208955
[TBL] [Abstract][Full Text] [Related]
36. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
Hassan H; Reis CA; Bennett EP; Mirgorodskaya E; Roepstorff P; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 2000 Dec; 275(49):38197-205. PubMed ID: 10984485
[TBL] [Abstract][Full Text] [Related]
37. Investigation of sequon engineering for improved O-glycosylation by the human polypeptide N-acetylgalactosaminyl transferase T2 isozyme and two orthologues.
Thompson NK; LeClaire LTN; Rodriguez Perez S; Wakarchuk WW
Biochem J; 2021 Oct; 478(19):3527-3537. PubMed ID: 34523671
[TBL] [Abstract][Full Text] [Related]
38. Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1).
Tenno M; Toba S; Kézdy FJ; Elhammer AP; Kurosaka A
Eur J Biochem; 2002 Sep; 269(17):4308-16. PubMed ID: 12199709
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
[TBL] [Abstract][Full Text] [Related]
40. Structural Analysis of a GalNAc-T2 Mutant Reveals an Induced-Fit Catalytic Mechanism for GalNAc-Ts.
de Las Rivas M; Coelho H; Diniz A; Lira-Navarrete E; Compañón I; Jiménez-Barbero J; Schjoldager KT; Bennett EP; Vakhrushev SY; Clausen H; Corzana F; Marcelo F; Hurtado-Guerrero R
Chemistry; 2018 Jun; 24(33):8382-8392. PubMed ID: 29601100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
